These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6814353)

  • 21. Diversity of determinants encoding carbenicillin, gentamicin, and tobramycin resistance in nosocomial Pseudomonas aeruginosa.
    Mucha DK; Farrand SK
    Antimicrob Agents Chemother; 1986 Aug; 30(2):281-9. PubMed ID: 3021051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serogrouping, plasmid and drug resistance of Pseudomonas aeruginosa in Taiwan.
    Ding MJ; Wu TM
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):165-78. PubMed ID: 3149572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmid-determined tobramycin and gentamicin resistance in strains of Pseudomonas aeruginosa from two Sydney hospitals.
    Sinclair MI; Asche V; Morgan AF; Holloway BW
    Med J Aust; 1981 Sep; 2(6):283-6,287. PubMed ID: 6795429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance due to aminoglycoside modifying enzymes in Pseudomonas aeruginosa isolates from burns patients.
    Shahid M; Malik A
    Indian J Med Res; 2005 Oct; 122(4):324-9. PubMed ID: 16394325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R factor-mediated resistance to aminoglycoside antibiotics in Pseudomonas aeruginosa.
    Sagai H; Krcmery V; Hasuda K; Iyobe S; Knothe H
    Jpn J Microbiol; 1975 Dec; 19(6):427-32. PubMed ID: 820894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide sequence of the aacC3 gene, a gentamicin resistance determinant encoding aminoglycoside-(3)-N-acetyltransferase III expressed in Pseudomonas aeruginosa but not in Escherichia coli.
    Vliegenthart JS; Ketelaar-van Gaalen PA; van de Klundert JA
    Antimicrob Agents Chemother; 1991 May; 35(5):892-7. PubMed ID: 1649572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotic resistance patterns during aminoglycoside restriction.
    Young EJ; Sewell CM; Koza MA; Clarridge JE
    Am J Med Sci; 1985 Dec; 290(6):223-7. PubMed ID: 3936358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of ionic strength in salt antagonism of aminoglycoside action on Escherichia coli and Pseudomonas aeruginosa.
    Beggs WH; Andrews FA
    J Infect Dis; 1976 Nov; 134(5):500-4. PubMed ID: 62813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Plasmid profiles of aminoglycoside-resistant Pseudomonas aeruginosa].
    Tsukada K
    Kansenshogaku Zasshi; 1990 Feb; 64(2):202-9. PubMed ID: 2110963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The ORF1 of the gentamicin-resistance operon (aac) of Pseudomonas aeruginosa encodes adenosine 5'-phosphosulphate kinase.
    Satishchandran C; Taylor JC; Markham GD
    Mol Microbiol; 1993 Sep; 9(6):1223-7. PubMed ID: 7934935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of gentamicin resistance in nosocomial infections.
    John JF; Rubens CE; Farrar WE
    Am J Med Sci; 1980; 279(1):25-30. PubMed ID: 6768292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in aminoglycoside use and gentamicin-resistant gram-negative clinical isolates in US academic medical centers: implications for antimicrobial stewardship.
    Ababneh M; Harpe S; Oinonen M; Polk RE
    Infect Control Hosp Epidemiol; 2012 Jun; 33(6):594-601. PubMed ID: 22561715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a gentamicin resistance gene probe for epidemiological studies.
    Groot Obbink DJ; Ritchie LJ; Cameron FH; Mattick JS; Ackerman VP
    Antimicrob Agents Chemother; 1985 Jul; 28(1):96-102. PubMed ID: 2994560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Study on in vitro activity of the antibiotics tobramycin and gentamicin against Pseudomonas aeruginosa clinical strains.
    Dámaso D; Moreno-López M
    J Antibiot (Tokyo); 1973 Apr; 26(4):233-7. PubMed ID: 4205651
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms.
    Larson TA; Peterson LR; Gerding DN
    J Clin Microbiol; 1985 Nov; 22(5):819-21. PubMed ID: 3932459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification and properties of two gentamicin-modifying enzymes, coded by a single plasmid pPK237 originating from Pseudomonas aeruginosa.
    Angelatou F; Litsas SB; Kontomichalou P
    J Antibiot (Tokyo); 1982 Feb; 35(2):235-44. PubMed ID: 6281224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The major aminoglycoside-modifying enzyme AAC(3)-II found in Escherichia coli determines a significant disparity in its resistance to gentamicin and amikacin in China.
    Xiao Y; Hu Y
    Microb Drug Resist; 2012 Feb; 18(1):42-6. PubMed ID: 22066787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.
    Reynolds AV; Hamilton-Miller JM; Brumfitt W
    Br Med J; 1974 Sep; 3(5934):778-80. PubMed ID: 4213265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Conjugation transfer of plasmid resistance to gentamycin and other antibiotics in clinical strains of Ps. aeruginosa].
    Moroz AF; Tiagunenko IuV; Kirova NZ
    Antibiotiki; 1977 Aug; 22(8):699-704. PubMed ID: 410358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.